Liv Body Review
Best for: Patients who want a single brand for both compounded GLP-1 medication and a supplement stack (whey protein, creatine, collagen, magnesium) for muscle-preservation pairing, and who are comfortable with limited supply-chain transparency in exchange for the integrated-brand convenience.
Liv Body (livbody.com, GLP-1 portal at go.livbody.com) is a direct-to-consumer supplement and wellness brand that added a compounded GLP-1 telehealth program with a distinctive integrated supplement-stack angle. Compounded semaglutide injection starts at $179/month; compounded tirzepatide injection starts at $279/month. The bundled monthly program starts at $249/month and includes medical consultation, ongoing provider support, and a customized treatment plan. Corporate entity: LivBody Wellness, LLC (per footer copyright on livbody.com). The brand's positioning is distinctive: a supplement company (whey protein, collagen, magnesium glycinate, creatine, fat-burner capsules) that integrates its own product line with compounded GLP-1 treatment, marketed as 'exclusive deals on targeted supplements to support your weight loss journey and maintain muscle.' Pharmacy partner is described generically as 'US-licensed pharmacy' without a specific name. States served, LegitScript ID, named medical director, governing law, and refund policy are not disclosed on the public-facing pages. Live-verified 2026-05-19.
Medium confidence · Last verified 2026-05-19 via manual · How we verify provider data
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
The Bottom Line
Liv Body is a solid telehealth option with balanced features and pricing.
Score Breakdown
Drugs Offered
Liv Body prescribes the following GLP-1 medications. Tap a drug to read our clinical guide with FDA label info, dosing schedules, side effects, and trial data.
Pricing
| Dose | Form | Price/mo |
|---|---|---|
| Starting tier | compounded | $179 |
| Starting tier | compounded | $279 |
| Bundled monthly program (consult + provider support + plan) | compounded | $249 |
✓ Pros
- •Integrated supplement-stack model is differentiated from pure-DTC competitors — patients get GLP-1 plus muscle-preservation supplements from the same brand
- •Corporate entity explicitly disclosed (LivBody Wellness, LLC) — better than many DTC competitors that hide ownership
- •Bundled $249/mo program includes consultation + ongoing provider support upfront (no hidden visit fees)
- •Semaglutide starting price ($179) is competitive with the broader DTC compounded market
- •Supplement product line ships from the same brand — convenience for patients who want bundled muscle-preservation pairing
✗ Cons
- •States-served list NOT disclosed publicly — buyers must check at checkout
- •Pharmacy partner NOT named (only 'US-licensed pharmacy' generic framing)
- •LegitScript certification NOT mentioned on the site
- •503A vs 503B designation NOT specified
- •Named medical director / clinician leadership NOT disclosed
- •Governing law / refund policy NOT publicly accessible
- •Supplement-stack integration creates upsell pressure — patients can buy GLP-1 elsewhere without the supplement push
- •Two-domain split (livbody.com supplements + go.livbody.com GLP-1) complicates trust signal vs unified-brand DTC competitors
Ready to start with Liv Body?
Starting at $179/month. See current pricing and start your free consultation.
Sources & methodology
Our Liv Body review applies the same 6-dimension scoring framework we use for every provider. Pricing, FDA approval status, compounding rules, and clinical-trial efficacy claims are sourced from the primary regulatory and peer-reviewed literature below.
Sources & methodology — as of May 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
Alternatives to Liv Body
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Frequently Asked Questions
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Ready to start with Liv Body?
Starting at $179/month. See current pricing and start your free consultation.